Hemophagocytic lymphohistiocytosis associated with dabrafenib and trametinib combination therapy following pembrolizumab administration for advanced melanoma

被引：21
|
作者：
Sasaki, K. [1 ]
Uehara, J. [1 ]
Iinuma, S. [1 ]
Doi, H. [1 ]
Honma, M. [1 ]
Toki, Y. [2 ]
Ishida-Yamamoto, A. [1 ]
机构：
[1] Asahikawa Med Univ, Dept Dermatol, Asahikawa, Hokkaido, Japan
[2] Asahikawa Med Univ, Dept Med, Div Gastroenterol & Hematol Oncol, Asahikawa, Hokkaido, Japan
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷 / 07期
关键词：
CYTOKINE;
D O I：
10.1093/annonc/mdy175
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1602 / 1603
页数：2
相关论文
共 50 条
  • [31] Epidermotropic progression of melanoma during therapy with dabrafenib and trametinib
    Ferrara, Gerardo
    Cacitti, Veronica
    Improta, Giuseppina
    Lo Re, Giovanni
    Corradin, Maria Teresa
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 75 (04) : E133 - E135
  • [32] Pembrolizumab-Associated Hepatitis and Hemophagocytic Lymphohistiocytosis Syndrome
    Ali, Asad
    Gupta, Nancy
    Roquiz, Woodlyne
    Ansari, Mohammad S.
    Murali, Arvind R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S1287 - S1287
  • [33] Facing the challenges of new melanoma-targeted therapies: Treatment of severe fevers associated with dabrafenib/trametinib combination therapy
    Lindsay, Julian N.
    Barras, Michael
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2015, 21 (04) : 293 - 295
  • [34] Severe gastrointestinal toxicity with administration of trametinib in combination with dabrafenib and ipilimumab
    Minor, David R.
    Puzanov, Igor
    Callahan, Margaret K.
    Hug, Bruce A.
    Hoos, Axel
    PIGMENT CELL & MELANOMA RESEARCH, 2015, 28 (05) : 611 - 612
  • [35] Optimizing combination dabrafenib and trametinib therapy in BRAF mutation-positive advanced melanoma patients: Guidelines from Australian melanoma medical oncologists
    Atkinson, Victoria
    Long, Georgina V.
    Menzies, Alexander M.
    McArthur, Grant
    Carlino, Matteo S.
    Millward, Michael
    Roberts-Thomson, Rachel
    Brady, Benjamin
    Kefford, Richard
    Haydon, Andrew
    Cebon, Jonathan
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 5 - 12
  • [36] Dabrafenib Therapy for Advanced Melanoma
    Van Anh Trinh
    Davis, Jennifer E.
    Anderson, Jaime E.
    Kim, Kevin B.
    ANNALS OF PHARMACOTHERAPY, 2014, 48 (04) : 519 - 529
  • [37] An unusual case with multiple epidermotropic melanoma metastases developing under combination therapy with dabrafenib and trametinib
    Gebhardt, C.
    Larribere, L.
    Maurier, N.
    Wetzel, S.
    Orouji, A.
    Utikal, J.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2015, 13 : 56 - 56
  • [38] Evolution of Melanocytic Nevi under Vemurafenib, Followed by Combination Therapy with Dabrafenib and Trametinib for Metastatic Melanoma
    Giurcaneanu, Calin
    Nitipir, Cornelia
    Popa, Liliana Gabriela
    Forsea, Ana Maria
    Popescu, Ioana
    Bumbacea, Roxana Silvia
    ACTA DERMATOVENEROLOGICA CROATICA, 2015, 23 (02) : 114 - 121
  • [39] Discrepancy in responses to dabrafenib plus trametinib combination therapy in intracranial and extracranial metastases in melanoma patients
    Kobayashi, Tadahiro
    Matsumoto, Sara
    Shimizu, Kyoko
    Miyake, Miho
    Maeda, Shintaro
    Hamaguchi, Yasuhito
    Matsushita, Takashi
    JOURNAL OF DERMATOLOGY, 2021, 48 (02): : E82 - E83
  • [40] First-line pembrolizumab versus dabrafenib/trametinib treatment for BRAF V600-mutant advanced melanoma
    Kim, Chang Gon
    Kim, Miso
    Hwang, Jieon
    Kim, Seung Tae
    Jung, Minkyu
    Kim, Kyoo Hyun
    Kim, Kyung Hwan
    Chang, Jee Suk
    Koom, Woong Sub
    Roh, Mi Ryung
    Chung, Kee Yang
    Kim, Tae Min
    Kim, Sang Kyum
    Lee, Jeeyun
    Shin, Sang Joon
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (05) : 989 - 996
12345